Buy @ $1.445
Q4 results were out last Friday AM. Revenue is higher but EPS flat, a bit lower (4.04ct vs 4.05ct – adjusted for 1-for-3 split) … Div maintained at 1.5ct, Cash increased + Debts slightly lower yoy… FCF 3.68ct, not too bad, considering cash flowing into devt of new hospitals… Analysts’ recommend Sell (CIMB) + Buy UOBKH)… make own call… Earnings likely to improve from 2H17 when Raffles Hospital Extension is completed… 😀